DIGESTIVE ADVANTAGE
Live / Registered — Registered (as of 22 Oct 2024)
What this means for you
Registered since 22 Oct 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98385997
- Registration number
- 7546316
- Mark type
- Design + words
- Filed
- 01 Feb 2024
- Published for opposition
- 07 May 2024
- Registered
- 22 Oct 2024
- Attorney of record
- Mark Lerner, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Dietary and nutritional supplements, non-prescription medical capsules for the dietary management of lactose intolerance, gas, bloating, constipation, diarrhoea, cramps, irritation, urgency, and abdominal discomfort; pharmaceutical preparations and substances for the treatment, relief or prevention of gastrointestinal conditions, disorders, diseases and discomfort; pharmaceutical preparations and substances for the promotion of digestive health; antacid preparations; digestives for pharmaceutical purposes; nutritional, dietary and dietetic substances for the treatment, relief or prevention of gastrointestinal conditions, disorders, diseases and discomfort
Owner
- RB Health (US) LLC, Parsippany, NJ, US
- RB Health (US) LLC, Parsippany, NJ, US
- RB Health (US) LLC, Parsippany, NJ, US
Prosecution history
- 22 Oct 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Oct 2024 — REGISTERED-PRINCIPAL REGISTER
- 16 Sept 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Sept 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Sept 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Jul 2024 — USE AMENDMENT FILED
- 07 Sept 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Jul 2024 — TEAS STATEMENT OF USE RECEIVED
- 02 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 May 2024 — PUBLISHED FOR OPPOSITION
- 17 Apr 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Mar 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Mar 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Mar 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE